These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2009369)

  • 1. Mutation of the p53 gene in human acute myelogenous leukemia.
    Slingerland JM; Minden MD; Benchimol S
    Blood; 1991 Apr; 77(7):1500-7. PubMed ID: 2009369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wild-type p53 is required for apoptosis induced by growth factor deprivation in factor-dependent leukaemic cells.
    Zhu YM; Bradbury DA; Russell NH
    Br J Cancer; 1994 Mar; 69(3):468-72. PubMed ID: 8123475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis.
    Lepelley P; Preudhomme C; Vanrumbeke M; Quesnel B; Cosson A; Fenaux P
    Leukemia; 1994 Aug; 8(8):1342-9. PubMed ID: 8057671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 gene mutations with chromosome 17 abnormalities in chronic myelogenous leukemia blast crisis patients persist in long-term cell lines but may be acquired in acute myeloid leukemia cells in vitro.
    Sen S; Zhou H; Andersson BS; Cork A; Freireich EJ; Stass SA
    Cancer Genet Cytogenet; 1995 Jul; 82(1):35-40. PubMed ID: 7627932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational inactivation of the p53 gene in the human erythroid leukemic K562 cell line.
    Law JC; Ritke MK; Yalowich JC; Leder GH; Ferrell RE
    Leuk Res; 1993 Dec; 17(12):1045-50. PubMed ID: 8246608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the p53 gene in patients with isochromosome 17q and Ph1-positive or -negative myeloid leukemia.
    Schütte J; Opalka B; Becher R; Bardenheuer W; Szymanski S; Lux A; Seeber S
    Leuk Res; 1993 Jun; 17(6):533-9. PubMed ID: 8505851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic alterations in the p53 gene in the blast crisis of chronic myelogenous leukemia: analysis by polymerase chain reaction based techniques.
    Neubauer A; He M; Schmidt CA; Huhn D; Liu ET
    Leukemia; 1993 Apr; 7(4):593-600. PubMed ID: 8464238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The abnormal p53 proteins expressed in CML cell lines are non-functional.
    Bi S; Lanza F; Goldman JM
    Leukemia; 1993 Nov; 7(11):1840-5. PubMed ID: 8231251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between molecular and clinical events in the evolution of chronic myelocytic leukemia to blast crisis.
    Foti A; Ahuja HG; Allen SL; Koduru P; Schuster MW; Schulman P; Bar-Eli M; Cline MJ
    Blood; 1991 Jun; 77(11):2441-4. PubMed ID: 2039825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of cell kinetics and cell cycle status by treating CD34+ chronic myeloid leukaemia cells with p53 antisense phosphorothioate oligonucleotides.
    Lanza F; Bi S; Moretti S; Castoldi G; Goldman JM
    Br J Haematol; 1995 May; 90(1):8-14. PubMed ID: 7786800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of the p53 tumour suppressor gene in haematologic neoplasms.
    Mori N; Wada M; Yokota J; Terada M; Okada M; Teramura M; Masuda M; Hoshino S; Motoji T; Oshimi K
    Br J Haematol; 1992 Jun; 81(2):235-40. PubMed ID: 1643020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P53 gene mutations in acute myelogenous leukaemia.
    Hu G; Zhang W; Deisseroth AB
    Br J Haematol; 1992 Aug; 81(4):489-94. PubMed ID: 1390233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p.
    Nakai H; Misawa S; Toguchida J; Yandell DW; Ishizaki K
    Cancer Res; 1992 Dec; 52(23):6588-93. PubMed ID: 1423304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent mutation of the p53 gene in human esophageal cancer.
    Hollstein MC; Metcalf RA; Welsh JA; Montesano R; Harris CC
    Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9958-61. PubMed ID: 2263646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic analysis of p53 and RB1 tumor-suppressor genes in blast crisis of chronic myeloid leukemia.
    Gaidano G; Serra A; Guerrasio A; Rege-Cambrin G; Mazza U; Saglio G
    Ann Hematol; 1994 Jan; 68(1):3-7. PubMed ID: 8110876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ras gene activation in a minor proportion of the blast population in acute myeloid leukemia.
    Toksoz D; Farr CJ; Marshall CJ
    Oncogene; 1987; 1(4):409-13. PubMed ID: 3330783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flt3 Y591 duplication and Bcl-2 overexpression are detected in acute myeloid leukemia cells with high levels of phosphorylated wild-type p53.
    Irish JM; Anensen N; Hovland R; Skavland J; Børresen-Dale AL; Bruserud O; Nolan GP; Gjertsen BT
    Blood; 2007 Mar; 109(6):2589-96. PubMed ID: 17105820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming activity of mutant human p53 alleles.
    Slingerland JM; Benchimol S
    J Cell Physiol; 1991 Sep; 148(3):391-5. PubMed ID: 1918170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism at codon 72 of the p53 gene in human acute myelogenous leukemia.
    Zhang W; Hu G; Deisseroth A
    Gene; 1992 Aug; 117(2):271-5. PubMed ID: 1639275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 in chronic myeloid leukemia cell lines.
    Bi S; Hughes T; Bungey J; Chase A; de Fabritiis P; Goldman JM
    Leukemia; 1992 Aug; 6(8):839-42. PubMed ID: 1640738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.